Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial.
Motovska Z, Hlinomaz O, Mrozek J, Kala P, Geisler T, Hromadka M, Akin I, Precek J, Kettner J, Cervinka P, Montalescot G, Jarkovsky J, Belohlavek J, Bis J, Matejka J, Vodzinska A, Muzafarova T, Tomasov P, Schee A, Bartus S, Andrasova A, Olivier CB, Kovarik A, Ostadal P, Demlova R, Souckova L, Vulev I, Coufal Z, Kochman J, Marinov I, Kubica J, Ducrocq G, Karpisek M, Klimsa Z, Hudec M, Widimsky P, Bhatt DL, Group DS. Motovska Z, et al. Among authors: cervinka p. EuroIntervention. 2024 Oct 21;20(20):e1309-e1318. doi: 10.4244/EIJ-D-24-00203. EuroIntervention. 2024. PMID: 39432252 Free article.
Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study.
Motovska Z, Hlinomaz O, Miklik R, Hromadka M, Varvarovsky I, Dusek J, Knot J, Jarkovsky J, Kala P, Rokyta R, Tousek F, Kramarikova P, Majtan B, Simek S, Branny M, Mrozek J, Cervinka P, Ostransky J, Widimsky P; PRAGUE-18 Study Group. Motovska Z, et al. Among authors: cervinka p. Circulation. 2016 Nov 22;134(21):1603-1612. doi: 10.1161/CIRCULATIONAHA.116.024823. Epub 2016 Aug 30. Circulation. 2016. PMID: 27576777 Clinical Trial.
1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor.
Motovska Z, Hlinomaz O, Kala P, Hromadka M, Knot J, Varvarovsky I, Dusek J, Jarkovsky J, Miklik R, Rokyta R, Tousek F, Kramarikova P, Svoboda M, Majtan B, Simek S, Branny M, Mrozek J, Cervinka P, Ostransky J, Widimsky P; PRAGUE-18 Study Group. Motovska Z, et al. Among authors: cervinka p. J Am Coll Cardiol. 2018 Jan 30;71(4):371-381. doi: 10.1016/j.jacc.2017.11.008. Epub 2017 Nov 14. J Am Coll Cardiol. 2018. PMID: 29154813 Free article. Clinical Trial.
Utilization of healthcare services in acute myocardial infarction and the risk of out-of-hospital cardiac death.
Motovska Z, Hlinomaz O, Hromadka M, Mrozek J, Precek J, Kala P, Muzafarova T, Kettner J, Matejka J, Bis J, Cervinka P, Tomasov P, Klechova A, Sanca O, Jarkovsky J. Motovska Z, et al. Among authors: cervinka p. Panminerva Med. 2024 Mar;66(1):79-81. doi: 10.23736/S0031-0808.23.04910-8. Epub 2023 Aug 3. Panminerva Med. 2024. PMID: 37535044 Free article. No abstract available.
Randomized comparison of endothelial progenitor cells capture stent versus cobalt-chromium stent for treatment of ST-elevation myocardial infarction. Six-month clinical, angiographic, and IVUS follow-up.
Bystroň M, Cervinka P, Spaček R, Kvašňák M, Jakabčin J, Cervinková M, Kala P, Widimský P. Bystroň M, et al. Among authors: cervinka p. Catheter Cardiovasc Interv. 2010 Nov 1;76(5):627-31. doi: 10.1002/ccd.22612. Catheter Cardiovasc Interv. 2010. PMID: 20506282 Clinical Trial.
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators. Vaduganathan M, et al. J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055. J Am Coll Cardiol. 2017. PMID: 28081827 Free article. Clinical Trial.
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX.
Cavender MA, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Lopes RD, Leonardi S, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL; CHAMPION PHOENIX Investigators*. Cavender MA, et al. Circ Cardiovasc Interv. 2022 Jan;15(1):e010390. doi: 10.1161/CIRCINTERVENTIONS.120.010390. Epub 2021 Dec 17. Circ Cardiovasc Interv. 2022. PMID: 34915723 Free PMC article. Clinical Trial.
Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS.
Jakabcin J, Spacek R, Bystron M, Kvasnák M, Jager J, Veselka J, Kala P, Cervinka P. Jakabcin J, et al. Among authors: cervinka p. Catheter Cardiovasc Interv. 2010 Mar 1;75(4):578-83. doi: 10.1002/ccd.22244. Catheter Cardiovasc Interv. 2010. PMID: 19902491 Clinical Trial.
Randomized comparison of 9-month stent strut coverage of biolimus and everolimus drug-eluting stents assessed by optical coherence tomography in patients with ST-segment elevation myocardial infarction. Long-term (5-years) clinical follow-up (ROBUST trial).
Jakl M, Cervinka P, Kanovsky J, Kala P, Poloczek M, Cervinkova M, Bezerra HG, Valenta Z, Costa MA. Jakl M, et al. Among authors: cervinka p. Cardiol J. 2023 Mar 10;30(6):921-8. doi: 10.5603/CJ.a2023.0013. Online ahead of print. Cardiol J. 2023. PMID: 36896638 Free PMC article.
79 results